NDC product
Buprenorphine HCl and Naloxone HCl
NDC 0406-1923 · SpecGx LLC
Key facts
| Product NDC | 0406-1923 |
|---|---|
| Proprietary name | Buprenorphine HCl and Naloxone HCl |
| Labeler | SpecGx LLC |
| Marketing category | ANDA |
| Application number | ANDA203136 |
| Marketing start | Feb 22, 2013 |
| Marketing end | Feb 28, 2021 |
| Listing certified through | Feb 28, 2021 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: